Zydus Lifesciences gets USFDA nod for multiple sclerosis drug; Concludes oncology plant inspection

Zydus Lifesciences received USFDA approval for its Diroximel Fumarate capsules for multiple sclerosis, while concluding a USFDA inspection at its oncology plant in Ahmedabad with two observations.

Leave a Reply

Your email address will not be published. Required fields are marked *